EMA

Agency's safety committee continues investigation of blood clots associated with the vaccine, to meet on March 18 to decide…

Ready to immediately ship initial doses of the agreed 200 million doses to the 27 EU member states, with an option for the EU to…

Longer observation periods can provide important additional and more precise information on longer-term safety and efficacy of a…

EMA starts rolling review, company to submit for USFDA EUA in coming weeks

Participants discussed ongoing activities of the three working groups established by the coalition that focus on vaccines…

The meeting participants stressed the need for large phase 3 clinical trials that enroll many thousands of people, including those…

Global fight against COVID-19 has found powerful tools in form AI, ML, big data, IoT technologies that are playing key role in…

International regulators came together, jointly developed these statements for healthcare professionals, general public to assure…

EMA therefore reiterates its previous advice that patients should continue to use ACE inhibitors or ARBs as advised by their…

The assessment of benefits, risks of Remdesivir is being performed under reduced timeline, opinion could be issued within weeks,…